BSE Live
Apr 17, 16:01Prev. Close
306.00
Open Price
314.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Apr 17, 15:52Prev. Close
306.15
Open Price
306.15
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
307.40 (14532)
| Balance Sheet of Advanced Enzyme Technologies (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 21.77 | 21.77 | 21.77 | 20.73 | 20.73 | |
| Total Share Capital | 21.77 | 21.77 | 21.77 | 20.73 | 20.73 | |
| Reserves and Surplus | 134.40 | 116.15 | 107.47 | 60.83 | 41.94 | |
| Total Reserves and Surplus | 134.40 | 116.15 | 107.47 | 60.83 | 41.94 | |
| Total Shareholders Funds | 156.17 | 137.91 | 129.23 | 81.56 | 62.67 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 5.15 | 15.13 | 26.90 | 34.31 | 36.99 | |
| Deferred Tax Liabilities [Net] | 14.77 | 14.45 | 13.26 | 5.30 | 7.01 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 19.92 | 29.57 | 40.16 | 39.61 | 44.00 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 22.38 | 31.74 | 23.40 | 30.87 | 26.76 | |
| Trade Payables | 7.53 | 9.08 | 17.73 | 17.17 | 8.48 | |
| Other Current Liabilities | 14.70 | 16.47 | 15.54 | 16.36 | 6.49 | |
| Short Term Provisions | 1.91 | 2.92 | 7.09 | 6.22 | 2.67 | |
| Total Current Liabilities | 46.51 | 60.21 | 63.75 | 70.62 | 44.40 | |
| Total Capital And Liabilities | 222.59 | 227.70 | 233.15 | 191.80 | 151.06 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 105.72 | 109.91 | 113.67 | 47.54 | 50.50 | |
| Intangible Assets | 0.01 | 0.01 | 0.02 | 0.06 | 0.19 | |
| Capital Work-In-Progress | 0.24 | 0.50 | 0.05 | 59.15 | 18.84 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 110.92 | 111.56 | 113.73 | 106.75 | 69.54 | |
| Non-Current Investments | 27.32 | 28.02 | 27.96 | 13.72 | 4.87 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 15.98 | 16.24 | 13.61 | 12.25 | 19.82 | |
| Other Non-Current Assets | 0.04 | 0.11 | 0.10 | 0.09 | 0.00 | |
| Total Non-Current Assets | 154.26 | 155.93 | 155.41 | 132.81 | 94.23 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 39.38 | 36.69 | 35.63 | 19.82 | 16.33 | |
| Trade Receivables | 0.95 | 28.44 | 33.53 | 28.28 | 21.87 | |
| Cash And Cash Equivalents | 24.42 | 1.84 | 1.92 | 3.34 | 9.91 | |
| Short Term Loans And Advances | 2.86 | 4.15 | 6.06 | 6.36 | 8.72 | |
| OtherCurrentAssets | 0.72 | 0.66 | 0.59 | 1.18 | 0.00 | |
| Total Current Assets | 68.33 | 71.77 | 77.74 | 58.98 | 56.83 | |
| Total Assets | 222.59 | 227.70 | 233.15 | 191.80 | 151.06 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 10.87 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 18.65 | 10.78 | 20.62 | 11.70 | 13.66 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.24 | 1.39 | 0.57 | 1.89 | 3.58 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 3.96 | 5.52 | 5.27 | 4.71 | 2.83 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | 0.53 | 1.58 | 1.02 | 0.51 | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 44.60 | 56.38 | 58.06 | 50.88 | 42.00 | |
| Other Earnings | -- | 0.07 | 0.97 | 0.42 | 0.16 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 15.55 | 15.55 | 15.55 | 15.55 | 15.55 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 27.32 | 28.02 | 27.96 | 13.72 | 4.87 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
03.02.2026
Advanced Enzyme Consolidated December 2025 Net Sales at Rs 171.95 crore, up 1.68% Y-o-Y
03.02.2026
Advanced Enzyme Standalone December 2025 Net Sales at Rs 95.58 crore, down 5.24% Y-o-Y
19.11.2025
Advanced Enzyme Consolidated September 2025 Net Sales at Rs 184.53 crore, up 26.31% Y-o-Y
13.11.2025
Advanced Enzyme Standalone September 2025 Net Sales at Rs 115.75 crore, up 49.59% Y-o-Y
03.02.2026
Advanced Enzyme Consolidated December 2025 Net Sales at Rs 171.95 crore, up 1.68% Y-o-Y
03.02.2026
Advanced Enzyme Standalone December 2025 Net Sales at Rs 95.58 crore, down 5.24% Y-o-Y
19.11.2025
Advanced Enzyme Consolidated September 2025 Net Sales at Rs 184.53 crore, up 26.31% Y-o-Y
13.11.2025
Advanced Enzyme Standalone September 2025 Net Sales at Rs 115.75 crore, up 49.59% Y-o-Y
13.04.2026
13.04.2026
10.04.2026
09.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth